南方医科大学深圳医院通过"港澳药械通"政策绿色通道，引进了欧洲原研舌下喷雾脱敏药物，用于治疗过敏性鼻炎1。该药物覆盖屋尘螨、粉尘螨、猫毛、狗毛三大高频过敏原1，采用每日1次、每次2喷（每喷0.1mL）的给药方式1。患者可在家中自行使用，无需前往医院进行传统的皮下注射治疗。
过敏性鼻炎是儿童常见病，我国患者超过2.5亿人，其中儿童患病率高达15.79%1。若未及时治疗，患儿进展为哮喘的概率可达30%1。舌下喷雾脱敏治疗为无痛无创的居家用药方案，相比传统皮下注射脱敏治疗，患者接受度和依从性更高1。脱敏治疗是全球公认、唯一能从根源上改变过敏疾病走向的"对因治疗"1，标准疗程为3-5年1。该脱敏药物已在欧洲、墨西哥等国家广泛使用多年1。
Southern Medical University Shenzhen Hospital has imported a European-originated sublingual spray desensitization medication through the "Hong Kong-Macau Pharmaceutical and Medical Device" policy green channel 1. The treatment targets three major high-frequency allergens: house dust mites, flour dust mites, cat hair, and dog hair 1. This at-home desensitization therapy represents a painless and non-invasive treatment option, offering significantly higher patient acceptance and compliance rates compared to traditional subcutaneous injection desensitization 1.
Allergic rhinitis affects over 250 million patients in China, with a pediatric prevalence rate of 15.79% 1. Notably, children with allergic rhinitis face a 30% risk of progressing to asthma 1. Desensitization treatment represents the globally recognized and only causal therapy capable of fundamentally altering the disease course from its root 1. The standard treatment course spans three to five years 1. The sublingual spray formulation is administered once daily with two sprays per dose, each spray containing 0.1 milliliters 1. This medication has been widely used for multiple years in European countries and Mexico 1.
评论
还没有评论，欢迎留下第一条。